Video · 2026-07-16 · 1h 26m · 6 moments

Zuckerberg Back on X Challenging Codex & Claude Code | SK Hynix’s $26BN IPO

✦ AI generated

timeline · colored by role

Mechanism

Anthropic is the single biggest beneficiary of California's unenforceable non-competes and its 'inevitable disclosure' doctrine, since departed employees can freely reuse knowledge from a former employer without needing to steal any documents.

Rory contrasts the Apple-OpenAI trade-secrets case with Anthropic's founding, arguing California's employee-friendly law let Anthropic's founders freely reuse knowledge from their old employer without stealing any physical documents or code.

transcript

Rory: Anthropic is the biggest beneficiary of the unability to enforce non-competes and the doctrine of inevitable disclosure. Cuz those seven employees who left, they basically walked out of them because they're way smarter than this guy. They probably didn't bring anything. No pieces of paper, no stolen code.

Prediction◆

The Apple lawsuit gives OpenAI a convenient excuse to kill its struggling hardware initiative, which had already lost its strategic rationale now that Jony Ive's team allegedly stole trade secrets and OpenAI no longer holds an unassailable lead.

Jason predicts OpenAI's Jony Ive-led hardware push is nearly certain to be cut, arguing the Apple lawsuit may be the pretext needed to pause a project that no longer makes strategic sense.

transcript

Jason: I'm all in. If we go back 60 weeks ago, I'm all in on persistent AI around us. So, Zuck, like with his new eyewear and all that, but this has got to be almost on the cutting board. It's like the Apple car. It's got to be close to being cut. And I think the reason this lawsuit may have happened is to push it over the line of getting cut. Just kill it, guys.

rebuts · 2

Claim

Meta's Spark 1.1 release, moving from free open-weight distribution to an aggressively priced paid API, means Meta is now competing toe-to-toe on the same commercial model as the frontier labs, which is bad news for OpenAI and Anthropic.

Rory says Meta's Spark 1.1 launch — abandoning open-weight generosity for a paid, aggressively-priced API — is a real competitive threat that OpenAI and Anthropic would have preferred not to see.

transcript

Rory: the big picture point is in the game using the same business model as everyone else entering the marketplace with the low price product big hit to competition I mean it's you know going toe-to-toe with the balance sheet to afford it right will it be ROI positive over five or 10 years to be the fourth player in the market selling at that price I don't know But, you know, if you're open AI and Entropic, you'd have preferred this not to happen.

Prediction

As AI spend shifts from unlimited token usage to hard budgets, every organization will need a cheaper model option, turning the mid-tier model market into a major competitive battleground.

Jason predicts that as companies move from unconstrained token spending to enforced budgets, fierce competition will emerge for cheaper models, a fight he calls 'the cheap seats.'

transcript

Jason: everyone's going to be token maxing if they aren't already. everyone's going to hit the limits. I finally hit my quad limits yesterday for the first time um on my max plan and I had to decide what to do, right? So, everyone every and as every organization goes from burn all the tokens you want baby to budgets, however you do it, whether it's automated, whether it's manual, whether it's picking a drop down, everyone's going to have to have a cheaper model.

gives example · 1supports · 1

Fact

SK Hynix, Samsung, and Micron form a de facto memory-chip oligopoly that has captured enormous profits from the AI capex boom, with SK Hynix's stock up 6x and its Korean shares hard for Americans to access directly.

Rory explains that SK Hynix, Samsung, and Micron form a memory-chip oligopoly that has profited enormously from the AI boom, with SK Hynix stock up 6x, setting up context for its record NASDAQ listing.

transcript

Rory: There are three memory companies. They have been a huge beneficiary of the AI capex boom in the last year. Those stock um skinex is up 6x, right? Two of the three are based in Korea. Samsung and SKH Highex, Micron is based in Idaho. go America and the truth is it's at igopoly they've made out like bandits and it's actually very hard to buy stocks in Korea

explains mechanism · 2

Claim◆

Venture investors with a board seat cannot invest in two direct competitors at the early stage, but at the late stage they structurally can and should, because late-stage private investing has effectively become a replacement for public markets, where holding competing positions is normal.

Rory argues that the rise of late-stage private financing functions as a replacement for public equity markets, meaning non-board investors can and should back multiple competitors in the same category, unlike early-stage board investors.

transcript

Rory: One of the bigs I've had is this. In the early stage when you're on the board you can't invest in two competitors. In the late stage structurally you have to and we'll talk about that not not have to but you you should be able to because the if you believe that the late stage is the replacement for what was the public markets for kind of high growth companies fidelity growth would have invested in open AI and entropic

explains mechanism · 1

Highlight slides

OpenAI's Hardware Bet Nears the Cutting Board✦ from: The Apple lawsuit gives OpenAI a convenient excuse to kill its struggling hardware initiative, which had already lost its strategic rationale now that Jony Ive's team allegedly stole trade secrets and OpenAI no longer holds an unassailable lead.Why the Rationale Collapsed✦ from: The Apple lawsuit gives OpenAI a convenient excuse to kill its struggling hardware initiative, which had already lost its strategic rationale now that Jony Ive's team allegedly stole trade secrets and OpenAI no longer holds an unassailable lead.Board seats block competing bets at early stage✦ from: Venture investors with a board seat cannot invest in two direct competitors at the early stage, but at the late stage they structurally can and should, because late-stage private investing has effectively become a replacement for public markets, where holding competing positions is normal.Late stage flips the rule: backing rivals becomes right✦ from: Venture investors with a board seat cannot invest in two direct competitors at the early stage, but at the late stage they structurally can and should, because late-stage private investing has effectively become a replacement for public markets, where holding competing positions is normal.

Related episodes

Video · The Cognitive Revolution

Fable's Back, AI Engineer Recap, & SambaNova

→

Video · All-In Podcast

OpenAI vs Anthropic IPOs, Anthropic $3T, Zuck's Price War, China Ends Open Source?, Trump Accounts

→

Video · BG2 Pod

The SpaceX IPO, Fable 5, AI Capex Update & Market Check w/ Gavin Baker, Andrew Fox & Clark Tang

→